Antibodies to coronavirus were produced in 92 percent of the body one month after the Oxford-Astragenecar vaccine (Covishield) and 98 percent two months later. Vaccine recipients who have a history of coronary heart disease are producing four times more antibodies.
The data came from a joint study by the Department of Health’s Institute of Pathology, Disease Control and Research (IEDCR) and the ICDDRB. This information has been revealed in a report published by IEDCR on Wednesday (May 12).
The IEDCR and ICDDRB have been conducting joint research on the presence of antibodies in the blood of vaccinators since the country began vaccinating Oxford-AstraZeneca on February 8. The study will review the presence of antibodies in the blood at different times in the next two years of vaccination among 6,300 vaccine recipients in different health centers of the country.
Preliminary results of the study show that 120 percent of the first-dose vaccine recipients produced antibodies 92 percent one month after the vaccine and 98 percent two months later. The presence of antibodies has been found in the body of vaccine recipients of all ages. There was no significant difference in the presence of antibodies with or without other diseases.
It appears that coronary antibodies are being produced in the body after vaccination among Bangladeshis. Ongoing research will provide up-to-date information on the presence of antibodies in the vaccine recipients in the future, the IEDCR said.
Source: Jago News 24